Gene · 1523
CUX1: cut like homeobox 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CUX1: cut like homeobox 1. Genes, record 1523. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1523
On this page
Gene
Proteins2
Reviewed human proteins whose Swiss-Prot entry states the gene.
Patents45
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 3506 | Q13948 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 3087 | P39880 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 3088 | Q13948 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14858 | P39880 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14859 | Q13948 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1152 | Q13948 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1152 | Q13948 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 3087 | P39880 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 3088 | Q13948 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 3506 | Q13948 | Espacenet |
1 to 10 of 45
See all 45 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,433
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CUX1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 17 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 12 | 2025 |
| R01GM100482 | Center for Critical Assessment of Structure Prediction (CASP) | 12 | 2025 |
| R01NS076511 | Lipid Imaging in Traumatic Brain Injury by High Resolution GCIB-secondary Ion Mass Spectrometry | 9 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 8 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 7 | 2025 |
| R01GM083144 | Characterization of mammalian COG complex-interacting Golgi trafficking machinery | 7 | 2025 |
| R35NS116843 | Continuous Neurogenesis in the Mammalian Hippocampus | 7 | 2025 |
| P30CA014599 | Cancer Center Support Grant | 6 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 6 | 2025 |
1 to 10 of 2,433Source NIH's project files
See all 2,433 nih grantsPapers2,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epilepsy with eyelid myoclonia in a patient with CUX1-related disorder. | Epileptic Disord | 2026 | 42799552 | PubTator, text mining | PubMed |
| Regulating Copper Nuclearity in Metal-Organic Frameworks for the Hydrogenation of Carbon Dioxide. | Small Methods | 2026 | 42608971 | PubTator, text mining | PubMed |
| T-cell lymphoma of the breast and ovary presenting as a second malignant neoplasm in a pediatric leukemia survivor: A case report and literature review. | Rare Tumors | 2026 | 42421762 | PubTator, text mining | PubMed |
| [Molecular and clinical characteristics and prognosis of myelodysplastic neoplasms with biallelic TET2 inactivation]. | Zhonghua Xue Ye Xue Za Zhi | 2026 | 42161655 | PubTator, text mining | PubMed |
| A transient sex-biased transcriptional program shapes early postnatal L2/3 neuron development. | Biol Sex Differ | 2026 | 41952201 | PubTator, text mining | PubMed |
| Second allogeneic stem cell transplantation for XMEN disease. | BMJ Case Rep | 2026 | 41871900 | PubTator, text mining | PubMed |
| Prognostic significance of CUX1 genomic deletion in myelodysplastic neoplasms. | Ann Hematol | 2026 | 41824036 | PubTator, text mining | PubMed |
| Myelodysplastic Syndrome (MDS) With KMT2A::CBL Rapidly Progressed to Acute Myeloid Leukaemia (AML). | EJHaem | 2026 | 41810210 | PubTator, text mining | PubMed |
| Cathepsins in prostate cancer: multifunctional regulators in tumor progression and therapeutic prospects-a narrative review. | Transl Androl Urol | 2026 | 41809789 | PubTator, text mining | PubMed |
| Integrating molecular and immune biomarkers for precision therapy in hepatitis B: Associated hepatocellular carcinoma. | World J Hepatol | 2026 | 41809466 | PubTator, text mining | PubMed |
1 to 10 of 2,836
See all 2,836 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1523
GET https://conductscience.org/api/genes/v1/1523/patents?page=2